June 10, 2009 09:00 ET

SOHM Receives B.F.A.D. (Bureau of Food and Drug Administration) Registration for Generic Pharmaceutical Sales in the Philippines

B.F.A.D. Registration Opens Large-Scale Sales Channel in the US$1.8 Billion Philippines Pharmaceutical Market Which Is Growing at Over 10% Annually

BUENA PARK, CA--(Marketwire - June 10, 2009) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that the Company has received B.F.A.D. (Bureau of Food and Drug Administration) Registration for generic pharmaceutical sales in the Philippines. The Company has many open large-scale sales channels to take market share in the US$1.8 billion Philippines pharmaceutical market which is growing at over 10% annually. Generic pharmaceutical sales in the Philippines target market is expected to contribute revenue and enhance earnings per share in the current quarter.

Vice President for Corporate Strategy at SOHM, Inc., Shailesh Shah stated, "SOHM's strategy is to capture specific areas of the Philippines generic drug market and we have been very successful creating sales channels in this underserved market. The current role of the pharmaceutical industry's sales and marketing workforce will be replaced by a new model over the next ten years as the industry shifts from a mass-market to a target-market approach to increase revenue. In view of enormous growth prospects in the Asian pharmaceutical market we are far ahead of our competition in the development and implementation of our Asian sales strategy.

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact